Loomis, Sayles & Company’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $1.8M | Sell |
|
|||||
|
2018
Q3 | $5.1M | Sell |
|
|||||
|
2018
Q2 | $15M | Sell |
|
|||||
|
2018
Q1 | $20M | Sell |
|
|||||
|
2017
Q4 | $21.8M | Buy |
|
|||||
|
2017
Q3 | $16.6M | Sell |
|
|||||
|
2017
Q2 | $20.1M | Buy |
|
|||||
|
2017
Q1 | $9.94M | Sell |
|
|||||
|
2016
Q4 | $19.8M | Sell |
|
|||||
|
2016
Q3 | $23.9M | Sell |
|
|||||
|
2016
Q2 | $25.4M | Sell |
|
|||||
|
2016
Q1 | $82.5M | Buy |
|
|||||
|
2015
Q4 | $105M | Buy |
|
|||||
|
2015
Q3 | $76.6M | Buy |
|
|||||
|
2015
Q2 | $75.8M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $2.94M | Buy |
|